QIAGEN moves up after strong earnings and guidance, levels to watch The shares are up over 6.5% after the company turned in an earnings beat and raised guidance. At the current price of $21.28, next resistance is at $21.90. A big area of resistance stretching back several year is at $23.83. That will be an important test if and when shares get closer to that objective. Looking back on a ten year monthly chart will make that evident. Support is currently at $20.27.
QIAGEN sees FY15 adjusted EPS $1.16-1.18, consensus $1.10 Sees FY15 adjusted net sales to rise approximately 4% CER in 2015, as growth of about 7-8% CER in the core portfolio exceeds the adverse impact of approximately 3-4 percentage points from lower U.S. HPV sales. FY15 revenue consensus $1.32B.